Ligand Pharmaceuticals
LGND
£101.01
Share price
-0.67%
Change (1 day)
19.45%
Change (1 year)
EPS for Ligand Pharmaceuticals (LGND)
EPS in 2025 (TTM): -£5.59
According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -£5.33. In 2024 the company made an earnings per share (EPS) of -£0.03743 a decrease over its 2023 EPS that were of £2.16.
EPS history for Ligand Pharmaceuticals from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -£5.59 | 14821.64% |
| 2024 | -£0.03743 | -101.73% |
| 2023 | £2.16 | -245.96% |
| 2022 | -£1.48 | -157.23% |
| 2021 | £2.59 | -2571.43% |
| 2020 | -£0.10 | -100.46% |
| 2019 | £22.92 | 353.48% |
| 2018 | £5.05 | 1025% |
| 2017 | £0.45 | -700% |
| 2016 | -£0.07487 | -100.87% |
| 2015 | £8.65 | 1859.32% |
| 2014 | £0.44 | 5.36% |
| 2013 | £0.42 | 8.0704505322479E+18% |
| 2012 | £0.0000000000 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | £8.27 | -255.20% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -£0.27 | -94.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | £1.17 | -121.91% | 🇬🇧 UK |
 Merck MRK | £5.16 | -196.87% | 🇺🇸 USA |
 Pfizer PFE | £1.04 | -119.52% | 🇺🇸 USA |
 Eli Lilly LLY | £9.25 | -273.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £2.01 | -137.64% | 🇺🇸 USA |
 Baxter BAX | -£0.02246 | -99.58% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £6.79 | -227.35% | 🇺🇸 USA |